ASYMMETRIC DIMETHYLARGININE LEVELS AND ATHEROSCLEROSIS MARKERS IN CUSHING SYNDROME


Ozsurekci C. G. , Akturk M., Ozkan C., GÜLBAHAR Ö. , Altinova A. E. , Yalcin M., ...Daha Fazla

ENDOCRINE PRACTICE, cilt.22, ss.1088-1095, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 22 Konu: 9
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4158/ep15990.or
  • Dergi Adı: ENDOCRINE PRACTICE
  • Sayfa Sayıları: ss.1088-1095

Özet

Objective: As a consequence of hypercortisolism, Cushing syndrome (CS) is frequently observed with other diseases that are associated with atherosclerosis, including diabetes mellitus, dyslipidemia, hypertension, and obesity. Cardiovascular disease (CVD) is the primary cause of mortality and morbidity in CS. We investigate CVD risk markers such as asymmetric dimethylarginine (ADMA), lipoprotein-associated phospholipase A2 (Lp-PLA2), high-sensitive C-reactive protein (hsCRP), homocysteine, lipid levels, ankle-brachial index (ABI), and carotid intima-media thickness (CIMT) in CS.